<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00676013</url>
  </required_header>
  <id_info>
    <org_study_id>97-286</org_study_id>
    <nct_id>NCT00676013</nct_id>
  </id_info>
  <brief_title>Skin Substitutes in Burn Care</brief_title>
  <acronym>Quad</acronym>
  <official_title>The Use of Alloderm and Other Skin Substitutes in Acute Burn Treatment and Burn Scar Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Medical Branch, Galveston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Medical Branch, Galveston</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if using a DERMAL LAYER under skin grafts:

        1. will reduce scar formation of skin grafts

        2. will reduce burn wound contractures

        3. will improve functional outcome of joints requiring grafts

        4. will reduce healing times and potential complications of donor sites

      Compare scarring outcome of Dermal products
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>December 1997</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of dermal products for reduction in the formation of scar</measure>
    <time_frame>Time of Burn to 18th birthday</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of dermal products to assess burn wound contractures</measure>
    <time_frame>Time of burn to 18th birthday</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of dermal products for functional outcome of joints requiring grafts</measure>
    <time_frame>Time of burn to 18th birthday</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of dermal products for healing times and potential complications of donor sites</measure>
    <time_frame>Time of burn to 18th birthday</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">158</enrollment>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of AlloDerm with grafting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of Integra with grafting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of homograft with grafting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use of autograft only for grafting</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>AlloDerm</intervention_name>
    <description>Application of AlloDerm over full thickness burn following excision</description>
    <arm_group_label>1</arm_group_label>
    <other_name>artificial dermis</other_name>
    <other_name>human dermis</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Skin Biopsy</intervention_name>
    <description>Tissue Biopsy of study sites (AlloDerm, Integra, Homograft, Autograft only)</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Integra</intervention_name>
    <description>Application of skin substitute over full thickness burn following excision.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Skin substitute</other_name>
    <other_name>Artificial dermis</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Autograft</intervention_name>
    <description>Application of autograft over full thickness burn injury following excision of burn wound.</description>
    <arm_group_label>4</arm_group_label>
    <other_name>human skin</other_name>
    <other_name>donor site</other_name>
    <other_name>donor skin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Homograft</intervention_name>
    <description>Application of homograft skin over full thickness burn injury following excision of burn wound.</description>
    <arm_group_label>3</arm_group_label>
    <other_name>cadaver skin</other_name>
    <other_name>donor skin</other_name>
    <other_name>human skin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Burn injury requiring grafting

          -  0 years-90 years

        Exclusion Criteria:

          -  Partial thickness burns only
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David N Herndon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas Medical Branch, Galveston</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Medical Branch</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 26, 2007</study_first_submitted>
  <study_first_submitted_qc>May 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2008</study_first_posted>
  <last_update_submitted>September 6, 2011</last_update_submitted>
  <last_update_submitted_qc>September 6, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 7, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Burns</keyword>
  <keyword>Skin grafting</keyword>
  <keyword>AlloDerm</keyword>
  <keyword>Integra</keyword>
  <keyword>Homograft</keyword>
  <keyword>Autograft</keyword>
  <keyword>Burn Scar</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>August 6, 2012</submitted>
    <returned>September 5, 2012</returned>
    <submitted>December 10, 2012</submitted>
    <returned>January 16, 2013</returned>
    <submitted>June 12, 2015</submitted>
    <returned>July 9, 2015</returned>
    <submitted>September 30, 2015</submitted>
    <returned>October 30, 2015</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

